BIFIDO Co., Ltd. (KOSDAQ:238200)
2,990.00
-80.00 (-2.61%)
At close: Mar 31, 2025, 3:30 PM KST
BIFIDO Company Description
BIFIDO Co., Ltd. produces probiotics-based products in South Korea and internationally.
It offers bifidobacterium strain products, such as BGN4 for immune modulating; BORI used to treat rotavirus infection in infants; and AD011 for general intestinal health problems.
The company was founded in 1999 and is headquartered in Hongcheon-eup, South Korea.
BIFIDO Co., Ltd.
Country | South Korea |
Founded | 1999 |
Industry | Pharmaceutical Preparations |
Employees | 99 |
Contact Details
Address: 23-16 Nonggongdanji-gil Hongcheon South Korea | |
Phone | 82 3 3435 4962 |
Website | bifido.com |
Stock Details
Ticker Symbol | 238200 |
Exchange | KOSDAQ |
Stock Type | Common Stock |
Fiscal Year | January - December |
Reporting Currency | KRW |
SIC Code | 2834 |